Primrose Therapeutics Inc

-

Company Reg D Offering

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Primrose Therapeutics Inc
Firm
Fund #
CIK #0001499169
Sale2010-07-30 (1.5 M Offered, 0.8 M Sold)
Fund
Phone2126325404
Address875 Third Avenue
New York, New York 10022
Source [EDGAR]
Amount Raised ($k)
80064048032016002010201220142016
Company Details
Director
Custodian
Auditor
Marketer
Broker
Jurisdiction
Form D Offering
Filed2010-08-13 (D)
Exemption506
Remaining$750,000
DurationOne year or less
RevenueNot Applicable
DirectorsRole2011 - 2026
Jeffrey Edelman Executive Officer
Mark Kessel Executive Officer
Zachary Sharon Executive Officer
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com